Effect of dialysis modality and membrane transport characteristics on dialysate protein losses of patients on peritoneal dialysis

Peritoneal Dialysis International

Volumn 17, Issue 5, 1997, Pages 449-454

  Kathuria, Pranay ^a   Moore, Harold L ^a   Khanna, Ramesh ^a   Twardowski, Zbylut J ^a   Goel, Sharad ^a   Nolph, Karl D ^a  

^a University of Missouri   (United States)

Author keywords

Peritoneal equilibration test; Protein losses

Indexed keywords

ADULT; AGED; ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSATE; DIALYSIS MEMBRANE; HUMAN; MAJOR CLINICAL STUDY; MEMBRANE TRANSPORT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0030711690     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089701700507     Document Type: Article

References (38)

1. Blumenkrantz MJ, Gahl GM, Kopple JD, et al. Protein losses during peritoneal dialysis. Kidney Int 1981; 19:593-602.
2. Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski ZJ, Pyle WK. Continuous ambulatory peritoneal dialysis. Ann Intern Med 1978; 88:449-56.
3. Giangrande A, Limido A, Cantu P, Allaria P. SDS-Polyacrylamide electrophoresis of protein losses during continuous ambulatory peritoneal dialysis. Ric Clin Lab 1980; 10:117-20.
4. Katirtzouglou A, Oreopoulos DG, Husdan H, Leung M, Ogilive R, Dombros N. Reappraisal of protein losses in patients undergoing continuous ambulatory peritoneal dialysis. Nephron 1980; 26:230-3.
5. Rubin J, Nolph KD, Arfania D, et al. Protein losses in continuous ambulatory peritoneal dialysis. Nephron 1981; 28:218-21.
6. Young GA, Brownjohn AM, Parsons FM. Protein losses in patients receiving continuous ambulatory peritoneal dialysis. Nephron 1987; 45:196-201.
7. Young GA, Young JB, Young SM, et al. Nutrition and delayed hypersensitivity during continuous ambulatory peritoneal dialysis in relation to peritonitis. Nephron 1986; 43:177-86.
8. Burkart JM. Effect of peritoneal dialysis prescription and peritoneal membrane transport characteristics on nutritional status. Perit Dial Int 1995; 15(5):S20-35.
9. Johansson AC, Attman PO, Haraldsson B. The influence of peritoneal dialysis on nutritional status (Ab-stract). J Am Soc Nephrol 1996; 7:1450.
10. Churchill DN, Taylor DW, Keshaviah PR, and the CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7(2):198-207.
11. Teehan BP, Schleifer CR, Brown JM, Sigler HM, Raimondo J. Urea kinetic analysis and clinical outcome on CAPD. A five-year longitudinal study. In: Khanna E, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1990; 6:181-6.
12. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG. Serum albumin in patients on continuous ambulatory peritoneal dialysis - predictors and correlations with outcomes. J Am Soc Nephrol 1993; 3:1501-7.
13. Struijk DG, Krediet RT, Koomen GCM, Boeschoten EW, Arisz L. The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival.Perit Dial Int 1994; 14:121-6.
14. Nolph KD, Moore HL, Twardowski ZJ, Khanna R, Gamboa S, Keshaviah P. Continuous ambulatory peritoneal dialysis with a high flux membrane. ASAIO J 1993; 39:904-9.
15. Hylander B, Barkeling B, Rossner S. Eating behavior in continuous ambulatory peritoneal dialysis and hemodialysis patients. Am J Kidney Dis 1992; 20(6):592-7.
16. Twardowski ZJ, Nolph KD, Khanna R, et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
17. Twardowski ZJ. PET: A simpler approach for determining prescriptions for adequate dialysis therapy. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1990; 6:186-91.
18. Twardowski ZJ. Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 1989; 7:95-108.
19. Lo WK, Brendolan A, Prowant BF, et al. Changes in the peritoneal equilibration test in selected chronic peritoneal dialysis patients. J Am Soc Nephrol 1994; 4:1466-74.
20. Heinegard D, Tiderstrom G. Determination of serum creatinine by a direct calorimetric method. Clin Chim Acta 1973; 43:305-10.
21. Fabiny DL, Ertingshausen G. Automated reaction-rate method for determination of serum creatinine with the CentrifiChem. Clin Chem 1971; 17:696-700.
22. Murray R. Creatinine in methods. In: Pesce A, Kaplan L, eds. Clinical chemistry. St. Louis: C.V. Mosby, 1987:14-15.
23. Doumas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin with BCG. Clin Chim Acta 1971; 31:87-96.
24. Beng CG, Lim KL. An improved automated method for determination of serum albumin using bromocresol green. Am J Clin Pathol 1973; 59:14-21.
25. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 16:863-71.
26. Keshaviah PR, Nolph KD, Moore HL, et al. Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 1994; 4:1475-85.
27. Lo WK, Prowant BF, Moore HL, et al. Comparison of different measurements of lean body mass in normal individuals and in chronic peritoneal dialysis patients. Am J Kidney Dis 1994; 1:74-85.
28. Kagan A, Bar-Khayim Y, Schafer Z, Fainaru M. Heterogenicity in peritoneal transport during continuous ambulatory peritoneal dialysis and its impact on ultrafiltration, loss of macromolecules and plasma level of proteins, lipids and lipoproteins. Nephron 1993; 63:32-42.
29. Kagan A, Bar-Khayim Y. Role of peritoneal loss of albumin in the hypoalbuminemia of continuous ambulatory peritoneal dialysis patients: relationship to peritoneal transport of solutes. Nephron 1995; 71:314-20.
30. Burkart JM, Jordan J, Rocco MV. Cross sectional analysis of D/P creatinine ratios versus serum albumin levels in NIPD patients (Abstract). Perit Dial Int 1994; 14(Suppl 1):S18.
31. Harty JC, Boulton H, Venning MC, Gokal R. Is peritoneal permeability an adverse risk factor for malnutrition in CAPD patients? Miner Electrolyte Metab 1996; 22:97-101.
32. Rippe B. A three-pore model of peritoneal transport. Perit Dial Int 1993; 13(Suppl 2):S35-8.
33. Krediet RT, Zemel D, Struijk DG, Koomen GCM, Arisz L. Individual characterization of the peritoneal restriction barrier to macromolecules. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1991; 7:15-20.
34. Zemel D, Krediet RT, Koomen GCM, Struijk DG, Arisz L. Day to day variability of protein transport used as a method for analyzing peritoneal permeability in CAPD. Perit Dial Int 1991; 11:217-23.
35. Strauss FG, Holmes DL, Dennis RL. Dialysis adequacy indices in high membrane transporters treated with short-dwell peritoneal dialysis. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1995; 11:110-13.
36. Twardowski ZJ, Nolph KD, Khanna R, et al. Daily clearances with CAPD and NIPD. ASAIO Trans 1986; 23:575-9.
37. Twardowski ZJ, Ksiazek A, Majdan M, et al. Kinetics of continuous ambulatory peritoneal dialysis with four exchanges per day. Clin Nephrol 1981; 15:119-30.
38. Blake P, Burkart JM, Churchill DN, et al. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996; 16:448-56.